Search clinical trials for: ABO2102

Total 37 results

Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd

Recruiting

Study of ABO2102 in KRAS-Mutated Solid Tumors

Advanced / Metastatic Solid Tumor

China
Ruijin Hospital
Suzhou Abogen Biosciences Co., Ltd.

Recruiting

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Pancreatic Neoplasms | Other Solid Tumors

China
Suzhou Abogen Biosciences Co., Ltd.
The First Affiliated Hospital of Soochow University

Not yet recruiting

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

Solid Tumors
Ruijin Hospital
Abogen Life Sciences (Shanghai) Co., Ltd.

Recruiting

A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

Autoimmune Diseases

China
Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd

Active, not recruiting

Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

Varicella-zoster Virus

China
Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd

Recruiting

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Solid Tumor, Adult

China
Ruijin Hospital

Recruiting

A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)

B-cell Non-Hodgkin Lymphoma

China
Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd

Active, not recruiting

Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above

Respiratory Syncytial Virus

China
Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd

Active, not recruiting

Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above

Respiratory Syncytial Virus

China
Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd

Active, not recruiting

Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

Varicella-zoster Virus

China
Legend Biotech USA Inc

Active, not recruiting

DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer

Small Cell Lung Cancer Extensive Stage | Large Cell Neuroendocrine Carcinoma of the Lung

United States
A2 Healthcare Taiwan Corporation
GoldenMed BioTechnology

Withdrawn

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

Hepatocellular Carcinoma | Liver Fibrosis | HEPATITIS B CHRONIC

Taiwan
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors

Advanced Solid Tumors

China
Suzhou Abogen Biosciences Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

COVID-19

Philippines, Pakistan, United Arab Emirates, Indonesia
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase 1 Study of SHR-A2102 in Subjects With Advanced Solid Tumors.

Advanced Or Metastatic Solid Tumor Malignancies

China
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)

Muscular Invasive Bladder Cancer (MIBC)

China
Fudan University

Not yet recruiting

Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer

Advanced Breast Cancer

China
Henan Cancer Hospital

Not yet recruiting

Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

Solid Tumors

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

Advanced Gynecological Malignancy

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma

Advanced Urothelial Carcinoma

China
Fudan University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Pancreatic Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects

Locally Advanced or Metastatic Non-small Cell Lung Cancer

China
Henan Cancer Hospital

Not yet recruiting

SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer

TNBC - Triple-Negative Breast Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer

Advanced or Metastatic Esophageal Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

China
Shandong Suncadia Medicine Co., Ltd.

Recruiting

A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour

Advanced Malignant Tumour

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma

Locally Advanced or Metastatic Urothelial Carcinoma

China
Fudan University

Recruiting

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC)

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

Advanced or Metastatic Non-small Cell Lung Cancer

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma

Advanced Urothelial Carcinoma

China
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Metastatic Cervical Cancer | Recurrent Cervical Cancer

China
Fudan University

Recruiting

Reverse Triple Negative Immune Resistant Breast Cancer (Renaissance)

Triple-negative Breast Cancer

China
Fudan University
Chongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaborators

Recruiting

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor

China

Search clinical trials for: ABO2102

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations